Have you ever thought about taking part in a Medical Trial? By registering your details with MedTrials.co.uk, we are able to send your details directly to companies who are looking for volunteers to take part in their medical research studies.
Information about you is kept on a register that CROs, Pharmaceutical companies and Clinical Investigators can access to contact you regarding individual studies.
MedTrials.co.uk is a website that will put you in direct contact with Pharmaceutical Companies, CRO’s (Clinical Research Organisations) and Clinical Investigators that are running Phase I (1) and Phase II (2) clinical trials.
Medical trials are an integral part of the drug development process. Patient and volunteer participation is vital for continued medical research and these trials are carried out under strict regulations.
If at any point you feel that you have changed your mind and are no longer interested in undertaking a medical trial you can unsubscribe from our service. If you are already part way through a medical trial, speak to the Clinical Investigator and they will advise you of your options.
Clinical research companies often offer financial compensation for your time and expenses.
Janssen Biotech is seeking to expand the scope of Darzalex as a second-line combination treatment for multiple myeloma. Go to Source
Bayer’s Nexavar is the latest medicine currently available through the Cancer Drugs Fund that has failed to meet cost-effectiveness standards set by the National Institute for Health and Care Excellence. Go to Source
Hospital deaths from the most common form of pneumonia dropped 14 percent between 2009 and 2015, according to new research published online in Thorax, the journal of the British Thoracic Society (BTS) Go to Source
A “groundbreaking” new app designed to help healthcare staff tackle antibiotic resistance has been launched in Scotland. Go to Source
Compared with men who smoked marijuana, women did not experience a significant reduction in pain sensitivity, a new study reveals. Go to Source
Portola has been dealt a blow after its anticoagulation reversal drug AndexXa was rejected by the US Food and Drug Administration. Go to Source